Clinical Trials Study
Copyright ©The Author(s) 2023.
World J Hepatol. May 27, 2023; 15(5): 688-698
Published online May 27, 2023. doi: 10.4254/wjh.v15.i5.688
Table 3 Complications and length of hospital stay in the postoperative period, n (%)
                                Group

Variables
GTMI (n = 21)
CG (n = 20)
Total (n = 41)
P value
Postoperative complications
No15 (71.4)13 (65.0)28 (68.3)
Yes6 (28.6)7 (35.0)13 (31.7)0.65842
Intraoperative bleeding (n)2 (9.5)0 (0.0)2 (4.9)
TEP0 (0.0)1 (5.0)1 (2.4)
Paralytic ileus2 (9.5)1 (5.0)3 (7.3)
Anemia1 (4.8)1 (5.0)2 (4.9)
PNM0 (0.0)1 (5.0)1 (2.4)
SPO2 drop < 920 (0.0)2 (10.0)2 (4.9)
ARI1 (4.8)0 (0.0)1 (2.4)
Biliary fistula0 (0.0)1 (5.0)1 (2.4)-
Postoperative hospital stay (in days)
Mean (SD)5.4 ± 2.07.1 ± 3.96.2 ± 3.20.05961